Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status

Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression. Their bi-directional crosstalk has been proposed to facilitate tumor immunoevasion, yet the impact of immunosuppression and spatial h...

Full description

Bibliographic Details
Main Authors: Carlijn M. Lems, Gerhard A. Burger, Joost B. Beltman
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1219669/full
_version_ 1797745429025128448
author Carlijn M. Lems
Gerhard A. Burger
Joost B. Beltman
author_facet Carlijn M. Lems
Gerhard A. Burger
Joost B. Beltman
author_sort Carlijn M. Lems
collection DOAJ
description Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression. Their bi-directional crosstalk has been proposed to facilitate tumor immunoevasion, yet the impact of immunosuppression and spatial heterogeneity on the interplay between these processes remains to be characterized. Here we study the role of these factors using mathematical and spatial models. We first designed models incorporating immunosuppressive effects on T cells mediated via PD-L1 and the EMT-inducing cytokine Transforming Growth Factor beta (TGFβ). Our models predict that PD-L1-mediated immunosuppression merely reduces the difference in PD-L1 levels between EMT states, while TGFβ-mediated suppression also causes PD-L1 expression to correlate negatively with TGFβ within each EMT phenotype. We subsequently embedded the models in multi-scale spatial simulations to explicitly describe heterogeneity in cytokine levels and intratumoral heterogeneity. Our multi-scale models show that Interferon gamma (IFNγ)-induced partial EMT of a tumor cell subpopulation can provide some, albeit limited protection to bystander tumor cells. Moreover, our simulations show that the true relationship between EMT status and PD-L1 expression may be hidden at the population level, highlighting the importance of studying EMT and PD-L1 status at the single-cell level. Our findings deepen the understanding of the interactions between EMT and the immune response, which is crucial for developing novel diagnostics and therapeutics for cancer patients.
first_indexed 2024-03-12T15:23:10Z
format Article
id doaj.art-cc17b7a0b83a4c5bbcf5d006a6bb64cc
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-12T15:23:10Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-cc17b7a0b83a4c5bbcf5d006a6bb64cc2023-08-10T23:05:27ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-08-011410.3389/fimmu.2023.12196691219669Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 statusCarlijn M. LemsGerhard A. BurgerJoost B. BeltmanEpithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression. Their bi-directional crosstalk has been proposed to facilitate tumor immunoevasion, yet the impact of immunosuppression and spatial heterogeneity on the interplay between these processes remains to be characterized. Here we study the role of these factors using mathematical and spatial models. We first designed models incorporating immunosuppressive effects on T cells mediated via PD-L1 and the EMT-inducing cytokine Transforming Growth Factor beta (TGFβ). Our models predict that PD-L1-mediated immunosuppression merely reduces the difference in PD-L1 levels between EMT states, while TGFβ-mediated suppression also causes PD-L1 expression to correlate negatively with TGFβ within each EMT phenotype. We subsequently embedded the models in multi-scale spatial simulations to explicitly describe heterogeneity in cytokine levels and intratumoral heterogeneity. Our multi-scale models show that Interferon gamma (IFNγ)-induced partial EMT of a tumor cell subpopulation can provide some, albeit limited protection to bystander tumor cells. Moreover, our simulations show that the true relationship between EMT status and PD-L1 expression may be hidden at the population level, highlighting the importance of studying EMT and PD-L1 status at the single-cell level. Our findings deepen the understanding of the interactions between EMT and the immune response, which is crucial for developing novel diagnostics and therapeutics for cancer patients.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1219669/fullepithelial-mesenchymal transition (EMT)PD-L1immunoevasionordinary differential equationscellular Potts model
spellingShingle Carlijn M. Lems
Gerhard A. Burger
Joost B. Beltman
Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status
Frontiers in Immunology
epithelial-mesenchymal transition (EMT)
PD-L1
immunoevasion
ordinary differential equations
cellular Potts model
title Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status
title_full Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status
title_fullStr Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status
title_full_unstemmed Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status
title_short Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status
title_sort tumor mediated immunosuppression and cytokine spreading affects the relation between emt and pd l1 status
topic epithelial-mesenchymal transition (EMT)
PD-L1
immunoevasion
ordinary differential equations
cellular Potts model
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1219669/full
work_keys_str_mv AT carlijnmlems tumormediatedimmunosuppressionandcytokinespreadingaffectstherelationbetweenemtandpdl1status
AT gerhardaburger tumormediatedimmunosuppressionandcytokinespreadingaffectstherelationbetweenemtandpdl1status
AT joostbbeltman tumormediatedimmunosuppressionandcytokinespreadingaffectstherelationbetweenemtandpdl1status